SALL4 and gastric cancer: These findings encourage the exploration of SALL4 as a potential therapeutic target for GC diagnosis and treatment, prompting further investigation into its carcinogenic role and potential as a therapeutic target, as well as the development of drugs to target this transcription factor (TF).